Agios Pharmaceuticals (AGIO) EBITDA Margin Growth (5y) (2017 - 2025)
Agios Pharmaceuticals (AGIO) EBITDA Margin Growth (5y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Agios Pharmaceuticals |
2.01 Bn |
2.01 Bn |
19.43 Mn |
| Date | Value |
| Dec 31, 2025 |
-39,903.00 |
| Sep 30, 2025 |
-61,937.00 |
| Jun 30, 2025 |
-78,204.00 |
| Mar 31, 2025 |
-117,560.00 |
| Dec 31, 2024 |
-86,641.00 |
| Sep 30, 2024 |
-72,786.00 |
| Jun 30, 2024 |
-79,405.00 |
| Mar 31, 2024 |
-80,183.00 |
| Dec 31, 2023 |
-117,518.00 |
| Sep 30, 2023 |
-71,119.00 |
| Mar 31, 2023 |
-54,254.00 |
| Dec 31, 2022 |
-138,119.00 |
| Sep 30, 2022 |
-189,503.00 |
| Jun 30, 2022 |
-100,356.00 |
| Mar 31, 2022 |
-1.15 Mn |
| Mar 31, 2020 |
466,263.00 |
| Dec 31, 2019 |
-11,629.00 |
| Sep 30, 2019 |
-42,854.00 |
| Jun 30, 2019 |
-21,646.00 |
| Mar 31, 2019 |
-17,711.00 |